The results demonstrate that relatively simple and cost-effective interventions by a pharmacist can have significant results in improving health outcomes. On average, the diabetic patient participating in this study had a decrease in HAb1C levels of 2.1%. It is estimated that in the U.K a 1 % decrease in HAb1C levels results in a 21% decrease in the risk of death from diabetes complications. The results from this study reinforce similar conclusions from earlier similar studies that diabetes disease management saves money and improves outcomes.
Source: HM Choe et al. Proactive case management of high risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. American Journal of Managed Care 2005 11: 253-260.
Chart Source: Stratton I, Adler A, Neil H et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12.